75N93019C00054↗
Duke University received this contract from National Institutes of Health Niaid, National Institutes of Health: $14.25M obligated so far for health r&d services; health care services; applied research. It runs to 2030-12-31.
Key facts · data as of Oct 25, 2026
- Recipient
- Duke University
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Contracting office
- National Institutes of Health Niaid (75N930)
- Obligated to date
- $14.25M
- Potential value
- $184.41M
- Ends
- 2030-12-31
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 75N93019C00054, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75N93019C00054_7529_-NONE-_-NONE-
Duke University: all federal awards · Department of Health and Human Services: spending · National Institutes of Health Niaid: what it buys
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2020)
What it is
- Product or service
- Health R&D Services; Health Care Services; Applied Research (PSC AN12)
- Industry
- Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) (NAICS 541715)
- Contracting office
- National Institutes of Health Niaid (75N930)
- Competition
- Full and open competition · 5 offers received
- Pricing
- Cost no fee
- How it was bought
- Standalone contract
- Solicitation
- HHSNIHNIAIDBAA2018
- Where the work is
- Durham, NC · district NC-04
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
18 actions since 2023-03-13. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-09-29 | P00027 | Supplemental agreement (work within scope) | $0 | CIVICS, COMPONENT C |
| 2026-09-21 | P00026 | Funding only | -$950 | EO 14398 - COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE |
| 2026-07-23 | P00025 | Administrative change | -$141.2K | EO 14398 - COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE |
| 2025-12-19 | P00024 | Option exercised | $6.96M | COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 30, 2026) |
| 2025-09-25 | P00023 | Supplemental agreement (work within scope) | $257.8K | COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 30, 2026) |
| 2025-08-06 | P00022 | Supplemental agreement (work within scope) | $861.3K | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19,2025)::EOI COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE |
| 2025-07-14 | P00021 | Funding only | $806.1K | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19,2025)::EOI COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE |
| 2025-03-06 | P00020 | Supplemental agreement (work within scope) | $0 | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19,2025)::EOI COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE |
| 2024-09-25 | P00019 | Funding only | -$375.7K | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
| 2024-08-15 | P00018 | Supplemental agreement (work within scope) | $1.72M | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
| 2024-07-31 | P00017 | Administrative change | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
| 2024-04-19 | P00016 | Funding only | -$109.8K | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
| 2024-01-29 | P00015 | Option exercised | $781.3K | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
| 2023-12-18 | P00014 | Supplemental agreement (work within scope) | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
| 2023-08-21 | P00013 | Option exercised | $772.5K | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
| 2023-08-10 | P00012 | Supplemental agreement (work within scope) | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
| 2023-05-10 | P00011 | Administrative change | $0 | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
| 2023-03-13 | P00010 | Option exercised | $2.71M | EO14042 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2026) |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗